Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Delivery
  4. Fast Track Articles
  5. Fast Track Article
image of Nanostructured Lipid Carrier-based Topical Gels as Novel Drug Delivery System: A Comprehensive Overview

Abstract

Nanostructured lipid carriers (NLCs) are lipidic nanocarriers that recover the permanency and capacity of drug payloads. NLCs are well-known as second-generation lipid nanocarriers with an unstructured matrix, presenting potentially advantageous nanocarrier systems with marketable opportunities because of reproducible production methodologies and biocompatible lipidic excipients. These (NLCs) are now recognized as a very promising nanocarrier structure for the efficient delivery of drugs via different administration routes. In recent years, several NLC-based gels have been developed and evaluated for topical delivery of many drugs and other therapeutic agents. This review article presents an overview of NLC-based topical gels investigated to deliver drugs via ocular, dermal, and transdermal routes. In addition, the classification, manufacturing, characterizations, advantages, and disadvantages of NLCs are addressed in this article. We also discussed different evaluations of NLC-based topical gels.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdd/10.2174/0115672018335655241015062436
2024-10-18
2025-01-22

  • From This Site

    /content/journals/cdd/10.2174/0115672018335655241015062436
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Mohammadi-Samani S. Ghasemiyeh P. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res. Pharm. Sci. 2018 13 4 288 303 10.4103/1735‑5362.235156 30065762
    [Google Scholar]
  2. Viegas C. Patrício A.B. Prata J.M. Nadhman A. Chintamaneni P.K. Fonte P. Solid lipid nanoparticles vs. nanostructured lipid carriers: A comparative review. Pharmaceutics 2023 15 6 1593 10.3390/pharmaceutics15061593 37376042
    [Google Scholar]
  3. Paliwal R. Paliwal S.R. Kenwat R. Kurmi B.D. Sahu M.K. Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin. Ther. Pat. 2020 30 3 179 194 10.1080/13543776.2020.1720649 32003260
    [Google Scholar]
  4. Munir M. Zaman M. Waqar M.A. Khan M.A. Alvi M.N. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery. J. Liposome Res. 2023 2023 1 14 10.1080/08982104.2023.2268711 37840238
    [Google Scholar]
  5. Kumari L. Choudhari Y. Patel P. Gupta G.D. Singh D. Rosenholm J.M. Bansal K.K. Kurmi B.D. Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs. Life (Basel) 2023 13 5 1099 10.3390/life13051099 37240744
    [Google Scholar]
  6. Gandhi S. Shastri D.H. Lipid-based nanoparticulate drug delivery. Pharm. Nanotechnol. 2024 12 10.2174/0122117385275514231127062730 38185889
    [Google Scholar]
  7. Chauhan I. Yasir M. Verma M. Singh A.P. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv. Pharm. Bull. 2020 10 2 150 165 10.34172/apb.2020.021 32373485
    [Google Scholar]
  8. Marwah H. Dewangan H.K. Advancements in solid lipid nanoparticles and nanostructured lipid carriers for breast cancer therapy. Curr. Pharm. Des. 2024 30 37 2922 2936 10.2174/0113816128319233240725103706 39150028
    [Google Scholar]
  9. Zulfakar M.H. Shamsuddin N.A.M. Nanostructured lipid carriers for the delivery of natural bioactive compounds. Curr. Drug Deliv. 2023 20 2 127 143 10.2174/1567201819666220324094234 35331113
    [Google Scholar]
  10. López K.L. Ravasio A. González-Aramundiz J.V. Zacconi F.C. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) prepared by microwave and ultrasound-assisted synthesis: Promising green strategies for the nanoworld. Pharmaceutics 2023 15 5 1333 10.3390/pharmaceutics15051333 37242575
    [Google Scholar]
  11. Eroğlu C. Sinani G. Ulker Z. Current state of lipid nanoparticles (SLN and NLC) for skin applications. Curr. Pharm. Des. 2023 29 21 1632 1644 10.2174/1381612829666230803111120 37534479
    [Google Scholar]
  12. Anantaworasakul P. Chaiyana W. Michniak-Kohn B.B. Rungseevijitprapa W. Ampasavate C. Enhanced transdermal delivery of concentrated capsaicin from chili extract-loaded lipid nanoparticles with reduced skin irritation. Pharmaceutics 2020 12 5 463 10.3390/pharmaceutics12050463 32438539
    [Google Scholar]
  13. Banerjee S. Pillai J. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs. Expert Opin. Drug Metab. Toxicol. 2019 15 6 499 515 10.1080/17425255.2019.1621289 31104522
    [Google Scholar]
  14. Keck C.M. Specht D. Brüßler J. Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles. J. Control. Release 2021 338 149 163 10.1016/j.jconrel.2021.08.016 34389366
    [Google Scholar]
  15. Gunawan M. Boonkanokwong V. Current applications of solid lipid nanoparticles and nanostructured lipid carriers as vehicles in oral delivery systems for antioxidant nutraceuticals: A review. Colloids Surf. B Biointerfaces 2024 233 113608 10.1016/j.colsurfb.2023.113608 37925866
    [Google Scholar]
  16. Patel P. Patel M. Nanostructured lipid carriers- A versatile carrier for oral delivery of lipophilic drugs. Recent Pat. Nanotechnol. 2021 15 2 154 164 10.2174/1872210514666200909154959 32912129
    [Google Scholar]
  17. Khan S. Sharma A. Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv. Pharm. Bull. 2023 13 3 446 460 10.34172/apb.2023.056 37646052
    [Google Scholar]
  18. Souto E.B. Baldim I. Oliveira W.P. Rao R. Yadav N. Gama F.M. Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin. Drug Deliv. 2020 17 3 357 377 10.1080/17425247.2020.1727883 32064958
    [Google Scholar]
  19. Czajkowska-Kośnik A. Szymańska E. Winnicka K. Nanostructured lipid carriers (NLC)-based gel formulations as etodolac delivery: From gel preparation to permeation study. Molecules 2022 28 1 235 10.3390/molecules28010235 36615429
    [Google Scholar]
  20. Amiri M. Jafari S. Kurd M. Mohamadpour H. Khayati M. Ghobadinezhad F. Tavallaei O. Derakhshankhah H. Sadegh Malvajerd S. Izadi Z. Engineered solid lipid nanoparticles and nanostructured lipid carriers as new generations of blood-brain barrier transmitters. ACS Chem. Neurosci. 2021 12 24 4475 4490 10.1021/acschemneuro.1c00540 34841846
    [Google Scholar]
  21. Jain N. Ghosh S. Tiwari T. Nagaich U. A Detailed insight into nanostructured lipid carriers: A versatile drug delivery system. Recent Pat. Nanotechnol. 2023 17 4 284 306 10.2174/1872210516666220523121733 35616677
    [Google Scholar]
  22. Hasnain M.S. Rishishwar P. Ali S. Alkahtani S. Tabish M. Milivojevic M. Ansari M.T. Nayak A.K. Formulation and ex vivo skin permeation of lidocaine HCl topical gels using dillenia (Dillenia indica L.) fruit gum. Rev. Mex. Ing. Quim. 2020 19 3 1465 1476 10.24275/rmiq/Mat1185
    [Google Scholar]
  23. Singhvi G. Banerjee S. Rapalli V.K. Dubey S.K. Khan S. Jha P.N. Gupta G. Dua K. Hasnain M.S. Nayak A.K. QbD-based formulation and optimization of topical hydrogel containing ketoconazole loaded cubosomes. Mater. Sci. Eng. C 2021 119 111548 10.1016/j.msec.2020.111548
    [Google Scholar]
  24. Jana S. Ali S.A. Nayak A.K. Sen K.K. Basu S.K. Development of topical gel containing aceclofenac-crospovidone solid dispersion by “Quality by Design (QbD)” approach. Chem. Eng. Res. Des. 2014 92 11 2095 2105 10.1016/j.cherd.2014.01.025
    [Google Scholar]
  25. Nayak A.K. Bera H. In situ polysaccharide-based gels for topical drug delivery applications. Polysaccharide Carriers for Drug Delivery. Maiti S. Jana S. United States Woodhead Publishing, Elsevier Inc. 2019 615 638 10.1016/B978‑0‑08‑102553‑6.00021‑0
    [Google Scholar]
  26. Kolawole O.M. Cook M.T. In situ gelling drug delivery systems for topical drug delivery. Eur. J. Pharm. Biopharm. 2023 184 36 49 10.1016/j.ejpb.2023.01.007 36642283
    [Google Scholar]
  27. D’Souza A. Shegokar R. Nanostructured lipid carriers (NLCs) for drug delivery: Role of liquid lipid (Oil). Curr. Drug Deliv. 2021 18 3 249 270 10.2174/1567201817666200423083807 32324512
    [Google Scholar]
  28. Syed Azhar S.N.A. Ashari S.E. Zainuddin N. Hassan M. Nanostructured lipid carriers-hydrogels system for drug delivery: Nanohybrid technology perspective. Molecules 2022 27 1 289 10.3390/molecules27010289 35011520
    [Google Scholar]
  29. Matsumoto M. Matsuo J. Dai M. Nishizawa T. Matsui K. Ichikawa Y. Okuwa M. Sugama J. Sanada H. Influence of differences in washing methods on skin texture. Int. J. Cosmet. Sci. 2014 36 2 175 181 10.1111/ics.12114 24438350
    [Google Scholar]
  30. Alkilani A. McCrudden M.T. Donnelly R. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015 7 4 438 470 10.3390/pharmaceutics7040438 26506371
    [Google Scholar]
  31. Ramadon D. McCrudden M.T.C. Courtenay A.J. Donnelly R.F. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv. Transl. Res. 2022 12 4 758 791 10.1007/s13346‑021‑00909‑6 33474709
    [Google Scholar]
  32. Jeong W.Y. Kwon M. Choi H.E. Kim K.S. Recent advances in transdermal drug delivery systems: a review. Biomater. Res. 2021 25 1 24 10.1186/s40824‑021‑00226‑6 34321111
    [Google Scholar]
  33. Sabbagh F. Kim B.S. Recent advances in polymeric transdermal drug delivery systems. J. Control. Release 2022 341 132 146 10.1016/j.jconrel.2021.11.025 34813879
    [Google Scholar]
  34. Phatale V. Vaiphei K.K. Jha S. Patil D. Agrawal M. Alexander A. Overcoming skin barriers through advanced transdermal drug delivery approaches. J. Control. Release 2022 351 361 380 10.1016/j.jconrel.2022.09.025 36169040
    [Google Scholar]
  35. Akhtar N. Khan R.A. Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions’. Prog. Lipid Res. 2016 64 192 230 10.1016/j.plipres.2016.08.005 27697511
    [Google Scholar]
  36. Guy R.H. Drug delivery to and through the skin. Drug Deliv. Transl. Res. 2024 14 8 2032 2040 10.1007/s13346‑024‑01614‑w 38837116
    [Google Scholar]
  37. Patel V. Mehta T. Shah J. Soni K. Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach. Drug Deliv. Transl. Res. 2024 10.1007/s13346‑024‑01685‑9 39145818
    [Google Scholar]
  38. Lauterbach A. Müller-Goymann C.C. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. Eur. J. Pharm. Biopharm 2015 97 (Pt A) 152 163 10.1016/j.ejpb.2015.06.020 26144664
    [Google Scholar]
  39. Desmet E. Van Gele M. Lambert J. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders. Expert Opin. Drug Deliv. 2017 14 1 109 122 10.1080/17425247.2016.1206073 27348356
    [Google Scholar]
  40. Zafar A. Imam S.S. Yasir M. Alruwaili N.K. Alsaidan O.A. Warsi M.H. Mir Najib Ullah S.N. Alshehri S. Ghoneim M.M. Preparation of NLCs-based topical erythromycin gel: In vitro characterization and antibacterial assessment. Gels 2022 8 2 116 10.3390/gels8020116 35200497
    [Google Scholar]
  41. Gorzelanny C. Mess C. Schneider S.W. Huck V. Brandner J.M. Skin barriers in dermal drug delivery: Which barriers have to be overcome and how can we measure them? Pharmaceutics 2020 12 7 684 10.3390/pharmaceutics12070684 32698388
    [Google Scholar]
  42. Yu Y.Q. Yang X. Wu X.F. Fan Y.B. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: Novel strategies for effective transdermal applications. Front. Bioeng. Biotechnol. 2021 9 646554 10.3389/fbioe.2021.646554 33855015
    [Google Scholar]
  43. Raina N. Rani R. Thakur V.K. Gupta M. New insights in topical drug delivery for skin disorders: From a nanotechnological perspective. ACS Omega 2023 8 22 19145 19167 10.1021/acsomega.2c08016 37305231
    [Google Scholar]
  44. Sharma P. Kaul S. Jain N. Pandey M. Nagaich U. Enhanced skin penetration and efficacy: First and second generation lipoidal nanocarriers in skin cancer therapy. AAPS PharmSciTech 2024 25 6 170 10.1208/s12249‑024‑02884‑w 39044049
    [Google Scholar]
  45. Salvi V.R. Pawar P. Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. J. Drug Deliv. Sci. Technol. 2019 51 255 267 10.1016/j.jddst.2019.02.017
    [Google Scholar]
  46. Elmowafy M. Al-Sanea M.M. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies. Saudi Pharm. J. 2021 29 9 999 1012 10.1016/j.jsps.2021.07.015 34588846
    [Google Scholar]
  47. da Silva M.G. de Godoi K.R.R. Gigante M.L. Pavie Cardoso L. Paula Badan Ribeiro A. Developed and characterization of nanostructured lipid carriers containing food-grade interesterified lipid phase for food application. Food Res. Int. 2022 155 111119 10.1016/j.foodres.2022.111119 35400405
    [Google Scholar]
  48. Purohit D.K. Nandgude T.D. Poddar S.S. Nano-lipid carriers for topical application: Current scenario. Asian J. Pharm. 2016 10 1 9
    [Google Scholar]
  49. Joshi M.D. Prabhu R.H. Patravale V.B. Fabrication of nanostructured lipid carriers (NLC)-based gels from microemulsion template for delivery through skin. Methods Mol. Biol. 2019 2000 279 292 10.1007/978‑1‑4939‑9516‑5_19 31148022
    [Google Scholar]
  50. Hu F.Q. Jiang S.P. Du Y.Z. Yuan H. Ye Y.Q. Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 2006 314 1 83 89 10.1016/j.ijpharm.2006.01.040 16563671
    [Google Scholar]
  51. Yuan H. Wang L.L. Du Y.Z. You J. Hu F.Q. Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B Biointerfaces 2007 60 2 174 179 10.1016/j.colsurfb.2007.06.011 17656075
    [Google Scholar]
  52. Gomaa E. Fathi H.A. Eissa N.G. Elsabahy M. Methods for preparation of nanostructured lipid carriers. Methods 2022 199 3 8 10.1016/j.ymeth.2021.05.003 33992771
    [Google Scholar]
  53. Rao R.R. Pisay M. Kumar S. Kulkarni S. Pandey A. Kulkarni V.I. Mutalik S. Medium and large scale preparation of Nanostructured Lipid Carriers of asenapine maleate: Quality-by-design based optimization, production, characterization and performance evaluation. J. Drug Deliv. Sci. Technol. 2022 71 103275 10.1016/j.jddst.2022.103275
    [Google Scholar]
  54. Cirri M. Maestrini L. Maestrelli F. Mennini N. Mura P. Ghelardini C. Di Cesare Mannelli L. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Deliv. 2018 25 1 1910 1921 10.1080/10717544.2018.1529209 30451015
    [Google Scholar]
  55. Haider M. Abdin S.M. Kamal L. Orive G. Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics 2020 12 3 288 10.3390/pharmaceutics12030288 32210127
    [Google Scholar]
  56. Danaei M. Dehghankhold M. Ataei S. Hasanzadeh Davarani F. Javanmard R. Dokhani A. Khorasani S. Mozafari M.R. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 2018 10 2 57 10.3390/pharmaceutics10020057 29783687
    [Google Scholar]
  57. Kraisit P. Sarisuta N. Development of triamcinolone acetonide-loaded nanostructured lipid carriers (NLCs) for buccal drug delivery using the Box-Behnken design. Molecules 2018 23 4 982 10.3390/molecules23040982 29690622
    [Google Scholar]
  58. Rangaraj N. Pailla S.R. Shah S. Prajapati S. Sampathi S. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach. Drug Deliv. Transl. Res. 2020 10 5 1476 1494 10.1007/s13346‑020‑00803‑7 32519202
    [Google Scholar]
  59. Tetyczka C. Hodzic A. Kriechbaum M. Juraić K. Spirk C. Hartl S. Pritz E. Leitinger G. Roblegg E. Comprehensive characterization of nanostructured lipid carriers using laboratory and synchrotron X-ray scattering and diffraction. Eur. J. Pharm. Biopharm. 2019 139 153 160 10.1016/j.ejpb.2019.03.017 30905779
    [Google Scholar]
  60. Morakul B. Junyaprasert V.B. Sakchaisri K. Teeranachaideekul V. Cannabidiol-loaded nanostructured lipid carriers (NLCs) for dermal delivery: Enhancement of photostability, cell viability, and anti-inflammatory activity. Pharmaceutics 2023 15 2 537 10.3390/pharmaceutics15020537 36839859
    [Google Scholar]
  61. Poonia N. Kharb R. Lather V. Pandita D. Nanostructured lipid carriers: versatile oral delivery vehicle. Future Sci. OA 2016 2 3 FSO135 10.4155/fsoa‑2016‑0030 28031979
    [Google Scholar]
  62. Khan A.A. Mudassir J. Akhtar S. Murugaiyah V. Darwis Y. Freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: Statistical optimization, in vitro and in vivo evaluations. Pharmaceutics 2019 11 2 97 10.3390/pharmaceutics11020097 30823545
    [Google Scholar]
  63. Waghule T. Rapalli V.K. Gorantla S. Saha R.N. Dubey S.K. Puri A. Singhvi G. Nanostructured lipid carriers as potential drug delivery systems for skin disorders. Curr. Pharm. Des. 2020 26 36 4569 4579 10.2174/1381612826666200614175236 32534562
    [Google Scholar]
  64. Müller R. Petersen R. Hommoss A. Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev. 2007 59 6 522 530 10.1016/j.addr.2007.04.012 17602783
    [Google Scholar]
  65. del Pozo-Rodríguez A. Solinís M.Á. Rodríguez-Gascón A. Applications of lipid nanoparticles in gene therapy. Eur. J. Pharm. Biopharm. 2016 109 184 193 10.1016/j.ejpb.2016.10.016 27789356
    [Google Scholar]
  66. Varela-Fernández R. García-Otero X. Díaz-Tomé V. Regueiro U. López-López M. González-Barcia M. Isabel Lema M. Javier Otero-Espinar F. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. Eur. J. Pharm. Biopharm. 2022 172 144 156 10.1016/j.ejpb.2022.02.010 35183717
    [Google Scholar]
  67. Shahzadi I. Fürst A. Knoll P. Bernkop-Schnürch A. Nanostructured lipid carriers (NLCs) for oral peptide drug delivery: About the impact of surface decoration. Pharmaceutics 2021 13 8 1312 10.3390/pharmaceutics13081312 34452273
    [Google Scholar]
  68. Patil P. Shirkhedkar A. Nanostructured etodolac carriers in transdermal gel: Optimization and characterization. Pharm. Nanotechnol. 2023 11 3 276 293 10.2174/2211738511666230111110340 36635925
    [Google Scholar]
  69. Patel D. Dasgupta S. Dey S. Ramani Y.R. Ray S. Mazumder B. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: Preparation, characterization, and in vivo evaluation. Sci. Pharm. 2012 80 3 749 764 10.3797/scipharm.1202‑12 23008819
    [Google Scholar]
  70. Vanti G. Muti L. D’Ambrosio M. Grifoni L. Bergonzi M.C. Luceri C. Bilia A.R. Nanostructured lipid carriers can enhance oral absorption of khellin, a natural pleiotropic molecule. Molecules 2021 26 24 7657 10.3390/molecules26247657 34946734
    [Google Scholar]
  71. Ferreira K.C.B. Valle A.B.C.S. Paes C.Q. Tavares G.D. Pittella F. Nanostructured lipid carriers for the formulation of topical anti-inflammatory nanomedicines based on natural substances. Pharmaceutics 2021 13 9 1454 10.3390/pharmaceutics13091454 34575531
    [Google Scholar]
  72. Shinde U.A. Parmar S.J. Easwaran S. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea. Drug Dev. Ind. Pharm. 2019 45 7 1039 1051 10.1080/03639045.2019.1569026 30727789
    [Google Scholar]
  73. Stefanov S.R. Andonova V.Y. Lipid nanoparticulate drug delivery systems: Recent advances in the treatment of skin disorders. Pharmaceuticals 2021 14 11 1083 10.3390/ph14111083
    [Google Scholar]
  74. Reis S. Gomes M.J. Martins S. Ferreira D. Segundo M.A. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int. J. Nanomedicine 2014 9 1231 1242 10.2147/IJN.S45561 24634584
    [Google Scholar]
  75. Zhai Y. Zhai G. Advances in lipid-based colloid systems as drug carrier for topic delivery. J. Control. Release 2014 193 90 99 10.1016/j.jconrel.2014.05.054 24939745
    [Google Scholar]
  76. Agrawal Y. Petkar K.C. Sawant K.K. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int. J. Pharm. 2010 401 1-2 93 102 10.1016/j.ijpharm.2010.09.007 20858539
    [Google Scholar]
  77. Arora R. Katiyar S.S. Kushwah V. Jain S. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Expert Opin. Drug Deliv. 2017 14 2 165 177 10.1080/17425247.2017.1264386 27882780
    [Google Scholar]
  78. Waghule T. Rapalli V.K. Singhvi G. Manchanda P. Hans N. Dubey S.K. Hasnain M.S. Nayak A.K. Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in-vitro and ex-vivo evaluation. J. Drug Deliv. Sci. Technol. 2019 52 303 315 10.1016/j.jddst.2019.04.026
    [Google Scholar]
  79. Kapoor H. Aqil M. Imam S.S. Sultana Y. Ali A. Formulation of amlodipine nano lipid carrier: Formulation design, physicochemical and transdermal absorption investigation. J. Drug Deliv. Sci. Technol. 2019 49 209 218 10.1016/j.jddst.2018.11.004
    [Google Scholar]
  80. Imran M. Iqubal M.K. Imtiyaz K. Saleem S. Mittal S. Rizvi M.M.A. Ali J. Baboota S. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int. J. Pharm. 2020 587 119705 10.1016/j.ijpharm.2020.119705 32738456
    [Google Scholar]
  81. Iqbal B. Ali J. Baboota S. Silymarin loaded nanostructured lipid carrier: From design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement. J. Mol. Liq. 2018 255 513 529 10.1016/j.molliq.2018.01.141
    [Google Scholar]
  82. Mendes I.T. Ruela A.L.M. Carvalho F.C. Freitas J.T.J. Bonfilio R. Pereira G.R. Development and characterization of nanostructured lipid carrier-based gels for the transdermal delivery of donepezil. Colloids Surf. B Biointerfaces 2019 177 274 281 10.1016/j.colsurfb.2019.02.007 30763792
    [Google Scholar]
  83. Pardeike J. Schwabe K. Müller R.H. Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect. Int. J. Pharm. 2010 396 1-2 166 173 10.1016/j.ijpharm.2010.06.007 20541000
    [Google Scholar]
  84. Carbone C. Cupri S. Leonardi A. Puglisi G. Pignatello R. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization. Pharm. Pat. Anal. 2013 2 5 665 677 10.4155/ppa.13.43 24237173
    [Google Scholar]
  85. Xu H. Hu H. Zhao M. Shi C. Zhang X. Preparation of luteolin loaded nanostructured lipid carrier based gel and effect on psoriasis of mice. Drug Deliv. Transl. Res. 2023 2023 10.1007/s13346‑023‑01418‑4 37695445
    [Google Scholar]
  86. Garg N.K. Tandel N. Bhadada S.K. Tyagi R.K. Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases. Front. Pharmacol. 2021 12 713616 10.3389/fphar.2021.713616 34616297
    [Google Scholar]
  87. Patil A. Tuencar V. Gadad A. Dandagi P. Masareddy R. Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole. Ther. Deliv. 2021 12 8 565 574 10.4155/tde‑2021‑0029 34187177
    [Google Scholar]
  88. Baghel S. Nair V.S. Pirani A. Sravani A.B. Bhemisetty B. Ananthamurthy K. Aranjani J.M. Lewis S.A. Luliconazole‐loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections. Dermatol. Ther. 2020 33 6 e13959 10.1111/dth.13959 32618400
    [Google Scholar]
  89. Mahmood A. Rapalli V.K. Gorantla S. Waghule T. Singhvi G. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations. Drug Deliv. Transl. Res. 2022 12 5 1118 1135 10.1007/s13346‑021‑00986‑7 33895936
    [Google Scholar]
  90. Raut S. Gargate N. Ugale S. Gujar K.N. Kapare H. Formulation and development of hyaluronic acid based gel with ketoconazole-loaded nanostructured lipid carriers in fungal infection. Pharm. Nanotechnol. 2023 11 4 344 354 10.2174/2211738511666230310103017 36896905
    [Google Scholar]
  91. Rapalli V.K. Kaul V. Waghule T. Gorantla S. Sharma S. Roy A. Dubey S.K. Singhvi G. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur. J. Pharm. Sci. 2020 152 105438 10.1016/j.ejps.2020.105438 32598913
    [Google Scholar]
  92. Yuan M. Niu J. Li F. Ya H. Liu X. Li K. Fan Y. Zhang Q. Dipeptide-1 modified nanostructured lipid carrier-based hydrogel with enhanced skin retention and topical efficacy of curcumin. RSC Advances 2023 13 42 29152 29162 10.1039/D3RA04739C 37800130
    [Google Scholar]
  93. Zhao Z. Liu T. Zhu S. Yang Y. Wang Z. Ma H. Wang X. Liu T. Guo P. Pi J. Qi D. Tian B. Liu Z. Li N. Development and evaluation studies of Corylin loaded nanostructured lipid carriers gel for topical treatment of UV-induced skin aging. Exp. Gerontol. 2021 153 111499 10.1016/j.exger.2021.111499 34329721
    [Google Scholar]
  94. Javia A. Misra A. Thakkar H. Design and pharmacodynamic evaluation of DPK-060 loaded Nanostructured lipid carrier embedded gel for dermal delivery: A novel approach in the treatment of atopic dermatitis. Colloids Surf. B Biointerfaces 2022 217 112658 10.1016/j.colsurfb.2022.112658 35810608
    [Google Scholar]
  95. Alam M. Rizwanullah M. Mir S.R. Amin S. Statistically optimized tacrolimus and thymoquinone co-loaded nanostructured lipid carriers gel for improved topical treatment of psoriasis. Gels 2023 9 7 515 10.3390/gels9070515 37504393
    [Google Scholar]
  96. Hassan D.H. Shohdy J.N. El-Setouhy D.A. El-Nabarawi M. Naguib M.J. Compritol-based nanostrucutured lipid carriers (NLCs) for augmentation of zolmitriptan bioavailability via the transdermal route: in vitro optimization, ex vivo permeation, in vivo pharmacokinetic study. Pharmaceutics 2022 14 7 1484 10.3390/pharmaceutics14071484 35890379
    [Google Scholar]
  97. Carvajal-Vidal P. González-Pizarro R. Araya C. Espina M. Halbaut L. Gómez de Aranda I. García M.L. Calpena A.C. Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms. Int. J. Pharm. 2020 585 119480 10.1016/j.ijpharm.2020.119480 32479897
    [Google Scholar]
  98. Dadwal A. Mishra N. Narang R.K. Development and characterization of a clobetasol propionate nanostructured lipid carrier-based gel for the treatment of plaque psoriasis. Curr. Mol. Pharmacol. 2021 14 3 399 411 10.2174/1874467213666200628135552 32598275
    [Google Scholar]
  99. Raza H. Shah S.U. Ali Z. Khan A.U. Rajput I.B. Farid A. Mohaini M.A. Alsalman A.J. Al Hawaj M.A. Mahmood S. Hussain A. Shah K.U. In vitro and ex vivo evaluation of fluocinolone acetonide-acitretin-coloaded nanostructured lipid carriers for topical treatment of psoriasis. Gels 2022 8 11 746 10.3390/gels8110746 36421568
    [Google Scholar]
  100. Sharma N. Kumar S. Joshi G. Choudhary D. Formulation and characterization of febuxostat loaded nanostructured lipid carriers (NLCs) - gel for topical treatment of gout. Recent Pat. Nanotechnol. 2022 16 3 250 258 10.2174/1872210515666210415114118 33858317
    [Google Scholar]
  101. Unnisa A. Chettupalli A.K. Alazragi R.S. Alelwani W. Bannunah A.M. Barnawi J. Amarachinta P.R. Jandrajupalli S.B. Elamine B.A. Mohamed O.A. Hussain T. Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: Statistical optimization and pharmacological evaluations. Pharmaceuticals (Basel) 2023 16 8 1151 10.3390/ph16081151 37631066
    [Google Scholar]
  102. Burhan A.M. Klahan B. Cummins W. Andrés-Guerrero V. Byrne M.E. O’Reilly N.J. Chauhan A. Fitzhenry L. Hughes H. Posterior segment ophthalmic drug delivery: Role of muco-adhesion with a special focus on chitosan. Pharmaceutics 2021 13 10 1685 10.3390/pharmaceutics13101685 34683978
    [Google Scholar]
  103. Amrutkar C.S. Patil S.B. Nanocarriers for ocular drug delivery: Recent advances and future opportunities. Indian J. Ophthalmol. 2023 71 6 2355 2366 10.4103/ijo.IJO_1893_22 37322644
    [Google Scholar]
  104. Diebold Y. Calonge M. Applications of nanoparticles in ophthalmology. Prog. Retin. Eye Res. 2010 29 6 596 609 10.1016/j.preteyeres.2010.08.002 20826225
    [Google Scholar]
  105. Pal K. Anis A. Nayak A.K. Maji S. A scientometric review of hydrogel-based ocular drug delivery systems. Advances and Challenges in Pharmaceutical Technology: Materials. Nayak A.K. Pal K. Banerjee I. Maji S. Nanda U. USA Process Development and Drug Delivery Strategies Academic Press, Elsevier Inc. 2021 517 537 10.1016/B978‑0‑12‑820043‑8.00011‑6
    [Google Scholar]
  106. Nayak A.K. Hasnain M.S. Aminabhavi T.M. Torchilin V.P. Nanovesicular systems in drug delivery. Systems of Nanovesicular Drug Delivery. Nayak A.K. Hasnain M.S. Aminabhavi T.M. Torchilin V.P. United States Academic Press, Elsevier Inc. 2022 1 15 10.1016/B978‑0‑323‑91864‑0.00026‑7
    [Google Scholar]
  107. Lee H. Noh H. Advancements in nanogels for enhanced ocular drug delivery: Cutting-edge strategies to overcome eye barriers. Gels 2023 9 9 718 10.3390/gels9090718 37754399
    [Google Scholar]
  108. Wang C. Pang Y. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases. Adv. Drug Deliv. Rev. 2023 194 114721 10.1016/j.addr.2023.114721 36773886
    [Google Scholar]
  109. Sánchez-López E. Espina M. Doktorovova S. Souto E.B. García M.L. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery. Eur. J. Pharm. Biopharm. 2017 110 70 75 10.1016/j.ejpb.2016.10.009 27789358
    [Google Scholar]
  110. Das B. Nayak A.K. Mallick S. Nanovesicles for delivery of antifungal drugs. Systems of Nanovesicular Drug Delivery. Nayak A.K. Hasnain M.S. Aminabhavi T.M. Torchilin V.P. United States Academic Press, Elsevier Inc. 2022 383 397
    [Google Scholar]
  111. Youssef A. Dudhipala N. Majumdar S. Ciprofloxacin loaded nanostructured lipid carriers incorporated into in-situ gels to improve management of bacterial endophthalmitis. Pharmaceutics 2020 12 6 572 10.3390/pharmaceutics12060572 32575524
    [Google Scholar]
  112. Yu Y. Feng R. Li J. Wang Y. Song Y. Tan G. Liu D. Liu W. Yang X. Pan H. Li S. A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform. Asian Journal of Pharmaceutical Sciences 2019 14 4 423 434 10.1016/j.ajps.2018.08.002 32104471
    [Google Scholar]
  113. Abdelmonem R. Al-Samadi I.E.I. El Nashar R.M. Jasti B.R. El-Nabarawi M.A. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Drug Deliv. 2022 29 1 2868 2882 10.1080/10717544.2022.2115164 36065090
    [Google Scholar]
  114. Abla K.K. Hijazi S.M. Mehanna M.M. Augmented efficiency of azithromycin for MRSA ocular infections management: Limonene-based nanostructured lipid carriers in-situ approach. J. Drug Deliv. Sci. Technol. 2023 87 104764 10.1016/j.jddst.2023.104764
    [Google Scholar]
  115. Youssef A.A.A. Dudhipala N. Majumdar S. Dual drug loaded lipid nanocarrier formulations for topical ocular applications. Int. J. Nanomedicine 2022 17 2283 2299 10.2147/IJN.S360740 35611213
    [Google Scholar]
  116. Yu Y. Xu S. Yu S. Li J. Tan G. Li S. Pan W. A hybrid genipin-cross-linked hydrogel/nanostructured lipid carrier for ocular drug delivery: Cellular, ex vivo, and in vivoevaluation. ACS Biomater. Sci. Eng. 2020 6 3 1543 1552 10.1021/acsbiomaterials.9b01800 33455373
    [Google Scholar]
  117. Gade S. Patel K.K. Gupta C. Anjum M.M. Deepika D. Agrawal A.K. Singh S. An ex vivo evaluation of moxifloxacin nanostructured lipid carrier enriched in situ gel for transcorneal permeation on goat cornea. J. Pharm. Sci. 2019 108 9 2905 2916 10.1016/j.xphs.2019.04.005 30978345
    [Google Scholar]
  118. Tavakoli N. Taymouri S. Saeidi A. Akbari V. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis. Pharm. Dev. Technol. 2019 24 7 891 901 10.1080/10837450.2019.1616755 31062987
    [Google Scholar]
  119. Tan G. Yu S. Li J. Pan W. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone. Int. J. Biol. Macromol. 2017 103 941 947 10.1016/j.ijbiomac.2017.05.132 28545971
    [Google Scholar]
  120. Liu R. Sun L. Fang S. Wang S. Chen J. Xiao X. Liu C. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies. Pharm. Dev. Technol. 2016 21 5 576 582 10.3109/10837450.2015.1026607 26024239
    [Google Scholar]
  121. Patil A. Lakhani P. Taskar P. Avula B. Majumdar S. Carboxyvinyl polymer and guar-borate gelling system containing natamycin loaded pegylated nanolipid carriers exhibit improved ocular pharmacokinetic parameters. J. Ocul. Pharmacol. Ther. 2020 36 6 410 420 10.1089/jop.2019.0140 32315560
    [Google Scholar]
  122. Qidwai A. Khan S. Md S. Fazil M. Baboota S. Narang J.K. Ali J. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug Deliv. 2016 23 4 1476 1485 10.3109/10717544.2016.1165310 26978275
    [Google Scholar]
  123. Uprit S. Kumar Sahu R. Roy A. Pare A. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm. J. 2013 21 4 379 385 10.1016/j.jsps.2012.11.005 24227958
    [Google Scholar]
  124. Vohra T. Kaur I. Heer H. Murthy R.R. Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer. Cancer Nanotechnol. 2013 4 1-3 1 12 10.1007/s12645‑013‑0032‑9 26069497
    [Google Scholar]
  125. Han F. Yin R. Che X. Yuan J. Cui Y. Yin H. Li S. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: Design, characterization and in vivo evaluation. Int. J. Pharm. 2012 439 1-2 349 357 10.1016/j.ijpharm.2012.08.040 22989987
    [Google Scholar]
  126. Das B. Nayak A.K. Mallick S. Thyme oil-containing fluconazole-loaded transferosomal bigel for transdermal delivery. AAPS PharmSciTech 2023 24 8 240 10.1208/s12249‑023‑02698‑2 37989918
    [Google Scholar]
  127. Puglia C. Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin. Drug Deliv. 2012 9 4 429 441 10.1517/17425247.2012.666967 22394125
    [Google Scholar]
  128. Müller R.H. Shegokar R. Keck C.M. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr. Drug Discov. Technol. 2011 8 3 207 227 10.2174/157016311796799062 21291409
    [Google Scholar]
/content/journals/cdd/10.2174/0115672018335655241015062436
Loading
Nanostructured Lipid Carrier-based Topical Gels as Novel Drug Delivery System: A Comprehensive Overview
Bentham Science Publishers ; https://doi.org/10.2174/0115672018335655241015062436
/content/journals/cdd/10.2174/0115672018335655241015062436
/content/journals/cdd/10.2174/0115672018335655241015062436
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: drug delivery ; Nanostructured lipid carriers ; topical applications ; topical gels ; lipidic excipients

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test